Overview

  • Product name
    HU-331
  • Description
    Potent cannabinoid quinone. Topoisomerase II inhibitor.
  • Biological description
    Potent cannabinoid quinone (EC50 = 0.2 μg/ml) with antineoplastic activity; antitumoriogenic and antiangiogenic in vitro and in vivo. Highly specific inhibitor of topoisomerase II.
  • Purity
    > 95%

Properties

References

This product has been referenced in:
  • Kogan NM  et al. HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor. Mol Cancer Ther 6:173-83 (2007). Read more (PubMed: 17237277) »
  • Kogan NM  et al. A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: a comparative in vivo study. J Pharmacol Exp Ther 322:646-53 (2007). Read more (PubMed: 17478614) »
  • Kogan NM  et al. Synthesis and antitumor activity of quinonoid derivatives of cannabinoids. J Med Chem 47:3800-6 (2004). Read more (PubMed: 15239658) »

See 1 Publication for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab120922.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up